These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25154867)

  • 1. Immunological basis of anti-Candida vaccines focused on synthetically prepared cell wall mannan-derived manno-oligomers.
    Paulovičová L; Paulovičová E; Bystrický S
    Microbiol Immunol; 2014 Oct; 58(10):545-51. PubMed ID: 25154867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate.
    Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
    Int Immunopharmacol; 2012 Oct; 14(2):179-87. PubMed ID: 22835427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cell response to Candida cell wall mannan derived branched α-oligomannoside conjugates in mice.
    Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
    J Microbiol Immunol Infect; 2015 Feb; 48(1):9-19. PubMed ID: 24239417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida antigens and immune responses: implications for a vaccine.
    Moragues MD; Rementeria A; Sevilla MJ; Eraso E; Quindos G
    Expert Rev Vaccines; 2014 Aug; 13(8):1001-12. PubMed ID: 24957934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.
    Nelson RD; Shibata N; Podzorski RP; Herron MJ
    Clin Microbiol Rev; 1991 Jan; 4(1):1-19. PubMed ID: 2004345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
    Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
    J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential dendritic cell responses to cell wall mannan of Candida albicans, Candida parapsilosis, and Candida dubliniensis.
    Nguyen TNY; Matangkasombut O; Ritprajak P
    J Oral Sci; 2018 Dec; 60(4):557-566. PubMed ID: 30429436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with mannan protects mice against systemic aspergillosis.
    Liu M; Machová E; Neščáková Z; Medovarská I; Clemons KV; Martinez M; Chen V; Bystrický S; Stevens DA
    Med Mycol; 2012 Nov; 50(8):818-28. PubMed ID: 22587733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of α- and β/α-linked mannooligosaccharides in antibody response against C. dubliniensis.
    Medovarská I; Bystrický S; Kossaczká Z; Machová E
    Glycoconj J; 2010 Oct; 27(7-9):697-702. PubMed ID: 21110087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining criteria for anti-mannan antibodies to protect against candidiasis.
    Cutler JE
    Curr Mol Med; 2005 Jun; 5(4):383-92. PubMed ID: 15977994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal cell wall vaccines: an update.
    Edwards JE
    J Med Microbiol; 2012 Jul; 61(Pt 7):895-903. PubMed ID: 22267544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model alpha-mannoside conjugates: immunogenicity and induction of candidacidal activity.
    Paulovicová L; Bystrický S; Paulovicová E; Karelin AA; Tsvetkov YE; Nifantiev NE
    FEMS Immunol Med Microbiol; 2010 Apr; 58(3):307-13. PubMed ID: 20113351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of branched α-oligomannoside structures on induction of anti-Candida humoral immune response.
    Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
    Scand J Immunol; 2013 Jun; 77(6):431-41. PubMed ID: 23488735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of Candida serology based on cell wall antigens].
    Müller J; Melchinger W
    Mycoses; 2004; 47 Suppl 1():2-10. PubMed ID: 15667356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida cell wall mannan: a polysaccharide with diverse immunologic properties.
    Domer JE
    Crit Rev Microbiol; 1989; 17(1):33-51. PubMed ID: 2669830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell immunity and vaccines against invasive fungal diseases.
    Ito JI
    Immunol Invest; 2011; 40(7-8):825-38. PubMed ID: 21815776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.
    Wu X; Lipinski T; Carrel FR; Bailey JJ; Bundle DR
    Org Biomol Chem; 2007 Nov; 5(21):3477-85. PubMed ID: 17943207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentration of interleukin 10, anti-mannan Candida antibodies and the fungal colonization of the gastrointestinal tract in patients with ulcerative colitis.
    Ksiadzyna D; Semianow-Wejchert J; Nawrot U; Wlodarczyk K; Paradowski L
    Adv Med Sci; 2009; 54(2):170-6. PubMed ID: 19758974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.